Financial statements Meditrade Poland
Balance sheet data of MEDITRADE POLAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|---|---|
| Total assets | 1 248 408,30 | 1 864 479,29 | 1 741 753,38 | 1 673 123,62 | 1 923 516,07 | 2 614 892,42 | 3 186 800,30 |
| A. Fixed assets | 2 293,00 | 823,00 | 0,00 | - | 0,00 | 436 423,57 | 400 913,84 |
| B. Current assets | 1 246 115,30 | 1 863 656,29 | 1 741 753,38 | 1 673 123,62 | 1 923 516,07 | 2 178 468,85 | 2 785 886,46 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | - | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | - | - | - | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 248 408,30 | 1 864 479,29 | 1 741 753,38 | 1 673 123,62 | 1 923 516,07 | 2 614 892,42 | 3 186 800,30 |
| A. Equity | -211 770,46 | -888 955,25 | -1 368 649,36 | -1 901 397,53 | -2 601 614,76 | -2 858 604,88 | 6 000,00 |
| B. Liabilities and provisions for liabilities | 1 460 178,76 | 2 753 434,54 | 3 110 402,74 | 3 574 521,15 | 4 525 130,83 | 5 473 497,30 | 6 502 037,28 |
| I. Long-term liabilities | 0,00 | - | - | - | - | 1 170,05 | 1 879,50 |
| II. Short-term liabilities | 1 460 178,76 | 2 752 955,25 | 3 104 865,73 | 3 567 004,83 | 4 437 254,56 | 5 337 586,12 | 6 495 366,27 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.